Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) Stock Price
Biodexa Pharmaceuticals plc American Depositary Shs (NASDAQ: BDRX) last traded at $1.27, up 0.79% on the session. The quote above updates while this page is open; the figures below are drawn from Biodexa Pharmaceuticals plc American Depositary Shs’s own filings and are restated only when a new one is published.
Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) company overview
Biodexa Pharmaceuticals plc American Depositary Shs trades on NASDAQ under the ticker BDRX. Its market capitalisation is $286.79 billion.
BDRX valuation
Valuation measures for Biodexa Pharmaceuticals plc American Depositary Shs, derived from the latest quote and its most recent SEC filing.
Market cap
$286.79B
Beta
1.22
BDRX trading statistics
Range and volume for BDRX over the past 52 weeks.
52-week high
$59.40
52-week low
$1.02
Volume
55.8K
Average volume
186.7K
Previous close
$1.26
Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) FAQs
What is the BDRX stock price today?
Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) last traded at $1.27, up 0.79% on the session. FurlPay quotes BDRX from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is BDRX listed on?
Biodexa Pharmaceuticals plc American Depositary Shs is listed on NASDAQ under the ticker symbol BDRX.
What is Biodexa Pharmaceuticals plc American Depositary Shs's market cap?
Biodexa Pharmaceuticals plc American Depositary Shs has a market capitalisation of $286.79 billion, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is BDRX's 52-week range?
Over the past 52 weeks BDRX has traded between $1.02 and $59.40.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001643918).
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.